XM Therapeutics
PrivateLast Round
Seed
Oct 10, 2023
Total Funding Raised
$375,000
Company Overview
XM Therapeutics is a biotechnology company developing novel therapies based on injectable extracellular matrix particles to repair and modulate diseased tissue for treating chronic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
XM Therapeutics Comparables
Compare XM Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ECM Therapeutics, Inc. | 81% | |
| Ventrix Bio | 77% | |
| TissueForm, Inc. | 67% | |
XM Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 10, 2023 |
XM Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longevity Investor Network | Seed |
| Slater Technology Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 10, 2023
$375K round led by Slater Technology Fund
XM Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about XM Therapeutics's valuation, stock price, and market status.